You are here

AbbVie

The biggest-selling pharma companies of 2023

EP Vantage

Wed, 01/4/23 - 05:20 pm

AbbVie's Vraylar, carrying $4B sales target, wins FDA label expansion in depression

Fierce Pharma

Mon, 12/19/22 - 10:05 pm

AbbVie leaves PhRMA, BIO: reports

Medical Marketing and Media

Thu, 12/15/22 - 11:20 pm

AbbVie, Ipsen exit R&D deals to cap off lousy year for Exicure

Fierce Biotech

Wed, 12/14/22 - 10:44 am

AbbVie slapped with age discrimination lawsuit, following other pharmas

Endpoints

Mon, 12/12/22 - 10:31 am

age discrimination

ASH: Roche touts Lunsumio's durable efficacy as AbbVie, Regeneron plot lymphoma bispecific battle

Fierce Pharma

Mon, 12/12/22 - 10:21 am

AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline

BioSpace

Tue, 12/6/22 - 10:42 am

HotSpot Therapeutics

drug development

autoimmune disease

BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn's Disease Markets, Spherix Reports

PR Newswire

Sun, 12/4/22 - 01:24 pm

Bristol Myers Squibb

ulcerative colitis

Crohn's Disease

gastroentrologists

10 Massachusetts Biopharma Companies Hiring Now

BioSpace

Fri, 12/2/22 - 11:18 am

Moderna Therapeutics

Intellia Therapeutics

Alloy Therapeutics

Werewolf Therapeutics

Sherlock Biosciences

AbbVie links up with London VC firm to map out new anti-inflammatory companies

Fierce Biotech

Tue, 11/29/22 - 10:42 am

venture capital

Deep Science Ventures

inflammatory diseases

Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits

Fierce Pharma

Sat, 11/26/22 - 07:11 pm

Teva Pharmaceutical

AbbVie's Roche-rivaling blood cancer bispecific gets FDA priority review, triggering Genmab payday

Fierce Biotech

Mon, 11/21/22 - 10:12 am

bispecific antibodies

relapsed or refractory large B-cell lymphoma

Optum to add biosimilars to formulary to tackle the massive cost of Humira

Fierce Healthcare

Wed, 11/16/22 - 11:16 pm

AbbVie inks $54M settlement to resolve Namenda 'pay-for-delay' lawsuit

Fierce Pharma

Tue, 11/15/22 - 06:37 pm

Alzheimer's disease

Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers

BioSpace

Mon, 11/14/22 - 10:59 am

corporate culture

Moderna Therapeutics

AbbVie Touts Subgroup Data in Phase II Atrial Fibrillation Miss

BioSpace

Tue, 11/8/22 - 11:04 am

atrial fibrillation

clinicla trials

This Biopharma Offspring Is All Grown Up

Medical Devices and Diagnostics Industry

Tue, 11/8/22 - 12:02 pm

AbbVie Drops Autoimmune Candidate, Prioritizes Skyrizi and Rinvoq

BioSpace

Tue, 11/1/22 - 11:04 am

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

Endpoints

Mon, 10/31/22 - 04:22 pm

Teva Pharmaceuticals

Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023

Clinical Trials Arena

Mon, 10/31/22 - 10:37 am

clinical trials

systemic lupus erythematosus

Swedish Orphan Biovitrum

Pages